63 filings
6-K
GMAB
Genmab
20 Dec 19
Current report (foreign)
11:25am
6-K
GMAB
Genmab
19 Dec 19
Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics
11:42am
6-K
GMAB
Genmab
17 Dec 19
Current report (foreign)
1:26pm
6-K
GMAB
Genmab
13 Dec 19
Current report (foreign)
7:54am
6-K
GMAB
Genmab
6 Dec 19
Current report (foreign)
12:00am
6-K
o6cwgg8q
6 Dec 19
Current report (foreign)
12:00am
6-K
nt8o388btefok
5 Dec 19
Genmab Achieves USD 100 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen
9:28am
6-K
cyarcnbo
19 Nov 19
Current report (foreign)
1:07pm
6-K
aphq5
13 Nov 19
Current report (foreign)
1:37pm
6-K
4rglfuc3
12 Nov 19
Current report (foreign)
4:42pm
6-K
tw4s9ob
12 Nov 19
Capital Increase in Genmab as a Result of Employee Warrant Exercise
3:08pm
6-K
6d9oopyi6
6 Nov 19
Interim Report for the First Nine Months Ended September 30, 2019
3:37pm
6-K
ms4yr26guxldv5q94
30 Oct 19
Current report (foreign)
5:11pm
6-K
21xn6ra6d80ln2lowv
22 Oct 19
Current report (foreign)
9:45am
6-K
wbxyuvpttpj6b
18 Oct 19
CHMP Issues Positive Opinion Recommending DARZALEX® (Daratumumab) in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma
9:25am
6-K
810sm
17 Oct 19
Current report (foreign)
1:19pm
6-K
4wl80sns2zxf
15 Oct 19
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2019
8:21am
6-K
5aljpuizpt8cm
2 Oct 19
Capital Increase in Genmab as a Result of Employee Warrant Exercise
3:50pm
6-K
h1mdodurm38y
26 Sep 19
Current report (foreign)
12:31pm
6-K
hoyatv2juxu8w95y
13 Sep 19
Current report (foreign)
1:24pm